Label: MG217 PSORIASIS THERAPEUTIC CONDITIONER- salicylic acid shampoo

  • NDC Code(s): 68093-7242-1
  • Packager: Wisconsin Pharmacal Company
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated March 21, 2016

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Salicylic Acid 3%

  • Purpose

    Psoriasis, Seborrheic Dermatitis, Dandruff Treatment

  • Uses

    For the temporary relief of these symptoms associate with psoriasis, seborrheic dermatitis or dandruff

    • itching
    • scaling
    • flaking,
    • reness
    • irritaion of the scalp

    Helps prevent recurrence.

  • Warnings

    For external use only.

  • Ask a doctor before use

    • if condition covers larger area of body, consult your doctor before using this product.
  • When using this product

    • avoid contact wtih the eyes. If contact occurs, rinse thoroughly with water.
  • Stop use and ask a doctor if

    • condition worsens or does not improve after regular use of this product as directed, consult a doctor.
  • Keep out of reach of children

    If swallowed, get medical help or contact a Poison Control Center Immediately.

  • Directions

    • wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly.
    • for best results, use at least twice a week or as directed by a physician.
  • Inactive Ingredients

    Purified water, Sodium laureth sulfate, Cocamidopropyl betaine, Lauryl glucoside, Sodium citrate, Coco-glucoside, Glyceryl oleate, Propanediol, Glycerin, Polyquaterinum-44, Sodium benzoate, Panthenol, Calendula officinalis flower extract, Chamomilla recutita (matricaria) flower extract, Propylene glycol, Citric acid, Chlorhexidine gluconate, Disodium EDTA

  • PRINCIPAL DISPLAY PANEL

    Image

  • INGREDIENTS AND APPEARANCE
    MG217 PSORIASIS THERAPEUTIC CONDITIONER 
    salicylic acid shampoo
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68093-7242
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.03 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM LAURETH SULFATE (UNII: BPV390UAP0)  
    COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)  
    MATRICARIA CHAMOMILLA FLOWERING TOP OIL (UNII: SA8AR2W4ER)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    LAURYL GLUCOSIDE (UNII: 76LN7P7UCU)  
    COCO GLUCOSIDE (UNII: ICS790225B)  
    GLYCERYL OLEATE (UNII: 4PC054V79P)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    POLYQUATERNIUM-44 (200000 MW) (UNII: TTD9VOM83O)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68093-7242-11 in 1 CARTON11/01/2015
    1283 g in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333D11/01/2015
    Labeler - Wisconsin Pharmacal Company (800873986)
    Establishment
    NameAddressID/FEIBusiness Operations
    Wisconsin Pharmacal Company800873986manufacture(68093-7242)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!